Hookipa Pharma (HOOK) Expected to Announce Quarterly Earnings on Friday

Hookipa Pharma (NASDAQ:HOOK) is expected to post its quarterly earnings results before the market opens on Friday, March 28th. Analysts expect Hookipa Pharma to post earnings of ($0.41) per share and revenue of $3.44 million for the quarter.

Hookipa Pharma Price Performance

HOOK opened at $1.22 on Thursday. The firm has a market capitalization of $14.71 million, a price-to-earnings ratio of -0.33 and a beta of 0.71. Hookipa Pharma has a one year low of $1.11 and a one year high of $10.50. The business has a 50 day simple moving average of $1.64 and a two-hundred day simple moving average of $2.66.

Analysts Set New Price Targets

HOOK has been the topic of a number of research analyst reports. HC Wainwright reissued a “neutral” rating on shares of Hookipa Pharma in a research report on Friday, January 10th. Royal Bank of Canada downgraded shares of Hookipa Pharma from an “outperform” rating to a “sector perform” rating and decreased their price target for the stock from $48.00 to $2.00 in a research note on Friday, December 20th.

About Hookipa Pharma

HOOKIPA Pharma Inc, a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors.